INDUCTION BY INTERLEUKIN-2 OF OLIGOCLONAL EXPANSION OF CULTURED TUMOR-INFILTRATING LYMPHOCYTES

被引:22
|
作者
FISHLEDER, AJ
FINKE, JH
TUBBS, R
BUKOWSKI, RM
机构
[1] CLEVELAND CLIN FDN,RES INST,IMMUNOL SECT,CLEVELAND,OH 44195
[2] CLEVELAND CLIN FDN,DEPT PATHOL,CLEVELAND,OH 44195
[3] CLEVELAND CLIN FDN,DEPT HEMATOL ONCOL,CLEVELAND,OH 44195
关键词
D O I
10.1093/jnci/82.2.124
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To better understand the modulatory effects of interleukin-2 (IL-2) on lymphocyte proliferation, we examined the clonality of the in vitro T-cell response by Southern blot hybridization. Tumor-infiltrating lymphocytes (TILs) grown in the presence of IL-2 for 15-26 days had detectable T-cell receptor beta-chain gene rearrangements, which indicated oligoclonal enhancement in culture in four of nine TIL samples. In contrast, none of 11 uncultured TIL samples had detectable gene rearrangements. Lack of detection in at least three of the five negative, cultured TIL samples could be explained by increased numbers of natural killer cells. We hypothesize that the oligoclonal expansion noted results from the enhanced response of immune-primed T cells to IL-2. [J Natl Cancer Inst 82: 124-128, 1990]. © 1990 Oxford University Press.
引用
收藏
页码:124 / 128
页数:5
相关论文
共 50 条
  • [21] IN-VITRO PREDICTORS OF THERAPEUTIC RESPONSE IN MELANOMA PATIENTS RECEIVING TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2
    SCHWARTZENTRUBER, DJ
    HOM, SS
    DADMARZ, R
    WHITE, DE
    YANNELLI, JR
    STEINBERG, SM
    ROSENBERG, SA
    TOPALIAN, SL
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (07) : 1475 - 1483
  • [22] USE OF TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN THE IMMUNOTHERAPY OF PATIENTS WITH METASTATIC MELANOMA - A PRELIMINARY-REPORT
    ROSENBERG, SA
    PACKARD, BS
    AEBERSOLD, PM
    SOLOMON, D
    TOPALIAN, SL
    TOY, ST
    SIMON, P
    LOTZE, MT
    YANG, JC
    SEIPP, CA
    SIMPSON, C
    CARTER, C
    BOCK, S
    SCHWARTZENTRUBER, D
    WEI, JP
    WHITE, DE
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (25): : 1676 - 1680
  • [23] COMBINATION IMMUNOTHERAPY FOR CANCER - SYNERGISTIC ANTITUMOR INTERACTIONS OF INTERLEUKIN-2, ALFA INTERFERON, AND TUMOR-INFILTRATING LYMPHOCYTES
    ROSENBERG, SA
    SCHWARZ, SL
    SPIESS, PJ
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (17): : 1393 - 1397
  • [24] PROPERTIES OF RECOMBINANT INTERLEUKIN 2-CULTURED TUMOR-INFILTRATING LYMPHOCYTES IN HUMAN-LUNG CANCER
    YANO, T
    YASUMOTO, K
    TOGAMI, M
    ISHIDA, T
    KIMURA, G
    SUGIMACHI, K
    NOMOTO, K
    INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (04) : 619 - 623
  • [25] SYNERGISTIC ACTIONS OF PICIBANIL (OK-432) ON RECOMBINANT INTERLEUKIN-2 INDUCTION OF TUMOR-INFILTRATING LYMPHOCYTE EXPANSION, CYTOTOXICITY, AND PHENOTYPIC DIFFERENTIATION
    LAFRENIERE, R
    BORKENHAGEN, K
    BRYANT, LD
    NG, E
    HAYTON, S
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (01): : 53 - 60
  • [26] FUNCTIONAL AND PHENOTYPIC ANALYSIS OF TUMOR-INFILTRATING LYMPHOCYTES ISOLATED FROM HUMAN PRIMARY AND METASTATIC LIVER-TUMORS AND CULTURED IN RECOMBINANT INTERLEUKIN-2
    TAKAGI, S
    CHEN, K
    SCHWARZ, R
    IWATSUKI, S
    HERBERMAN, RB
    WHITESIDE, TL
    CANCER, 1989, 63 (01) : 102 - 111
  • [27] Phenotypic and functional analysis of fresh and recombinant interleukin-2 cultured tumor-infiltrating lymphocytes derived from human malignant liver tumors.
    Yoong, KF
    Adams, DH
    IMMUNOLOGY, 1996, 89 : OX224 - OX224
  • [28] Phenotypic and functional analysis of fresh and recombinant interleukin-2 cultured tumor-infiltrating lymphocytes derived from human malignant liver tumors.
    Yoong, KF
    Adams, DH
    HEPATOLOGY, 1996, 24 (04) : 155 - 155
  • [29] DIFFERENTIAL-EFFECTS OF INTERLEUKIN-2 AND CD3 TRIGGERING ON CYTOKINE GENE-TRANSCRIPTION AND SECRETION IN CULTURED TUMOR-INFILTRATING LYMPHOCYTES
    FILGUEIRA, L
    ZUBER, M
    JURETIC, A
    LUSCHER, U
    CAETANO, V
    HARDER, F
    GAROTTA, G
    HEBERER, M
    SPAGNOLI, GC
    CELLULAR IMMUNOLOGY, 1993, 150 (01) : 205 - 218
  • [30] TUMOR-INFILTRATING LYMPHOCYTES
    KRADIN, RL
    BHAN, AK
    LABORATORY INVESTIGATION, 1993, 69 (06) : 635 - 638